Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 42
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Angiol Sosud Khir ; 17(2): 23-9, 2011.
Artigo em Russo | MEDLINE | ID: mdl-21983458

RESUMO

The study comprised a total of 107 patients (all men) after endured femoropopliteal bypass grafting above the genicular fissure with a synthetic stent graft manufactured by the Gore Company for stage IIB and III chronic arterial insufficiency of the lower extremities according to the Fontain-Pokrovsky classification. Group One I (control group) was composed of fifty-four patients permanently taking in the postoperative period at the out-patient stage pentoxiphylline (trental 400 mg 1 tablet 3 times daily) and xantinol nicotinate at a dose of 150 mg one tablet thrice daily. Group Two (Study Group) consisted of fifty-three patients taking after reconstructive vascular surgery at the out-patient stage in addition to pentoxiphylline and xantinol nicotinate acetylsalicylic acid (cardiomagnil 75 mg 1 tablet once daily). The Control Group patients within 3 to 6 months of follow up were found to have a considerable progressing improvement of the functional abilities of the microcirculatory bed requiring in 44 (81.5%) cases hospitalization to the Surgical Department for intensive vascular therapy. Despite this fact four (7.4%) patients within the time frame from 6 to 9 months after surgery developed thrombosis of the vascular implant requiring a repeat surgical intervention. In the Study Group patients, the degree of functional capabilities of the microcirculatory bed in the postoperative period was less considerable, reaching the maximum after 10-12 months of follow up, with eighteen (34.0%) patients requiring hospitalization for additional vascular therapy to perform. There were no cases of implants' thrombosis in the Study Group patients. Pathological alterations in the functional state of the peripheral vascular bed correlated with viscosimetric indices and activity of blood platelet aggregation. The addition of antithrombocytic agents to conservative postoperative therapy considerably improved the outcomes of surgical treatment.


Assuntos
Aspirina , Artéria Femoral , Oclusão de Enxerto Vascular/prevenção & controle , Doença Arterial Periférica/cirurgia , Artéria Poplítea , Enxerto Vascular/efeitos adversos , Aspirina/administração & dosagem , Aspirina/efeitos adversos , Coagulação Sanguínea/efeitos dos fármacos , Viscosidade Sanguínea/efeitos dos fármacos , Artéria Femoral/patologia , Artéria Femoral/transplante , Oclusão de Enxerto Vascular/sangue , Oclusão de Enxerto Vascular/etiologia , Oclusão de Enxerto Vascular/patologia , Humanos , Extremidade Inferior/irrigação sanguínea , Masculino , Pentoxifilina/administração & dosagem , Pentoxifilina/efeitos adversos , Doença Arterial Periférica/sangue , Doença Arterial Periférica/patologia , Agregação Plaquetária/efeitos dos fármacos , Inibidores da Agregação Plaquetária/administração & dosagem , Inibidores da Agregação Plaquetária/efeitos adversos , Artéria Poplítea/patologia , Artéria Poplítea/transplante , Período Pós-Operatório , Reoperação , Resultado do Tratamento , Enxerto Vascular/métodos , Grau de Desobstrução Vascular/efeitos dos fármacos , Vasodilatadores/administração & dosagem , Vasodilatadores/efeitos adversos , Niacinato de Xantinol/administração & dosagem
2.
Urologiia ; (6): 40-4, 2010.
Artigo em Russo | MEDLINE | ID: mdl-21427993

RESUMO

Long-term clinical experience with conservative treatment of Peyronie's disease has demonstrated that clinical efficacy of this therapy comprises maily anesthesia while erectile problems are not solved. Introduction of the drugs into the fibrous plaque is not adequate and hard to perform. Some drugs affect only some components of pathogenesis. For stabilization of the process it is recommended to use transdermal electrophoresis or phonophoresis. The search for new effective drugs and methods continues.


Assuntos
Corticosteroides/uso terapêutico , Interferon-alfa/uso terapêutico , Induração Peniana/tratamento farmacológico , Verapamil/uso terapêutico , Niacinato de Xantinol/uso terapêutico , Administração Cutânea , Corticosteroides/administração & dosagem , Eletroporação , Humanos , Interferon alfa-2 , Interferon-alfa/administração & dosagem , Masculino , Pessoa de Meia-Idade , Dor/prevenção & controle , Fonoforese , Proteínas Recombinantes , Resultado do Tratamento , Verapamil/administração & dosagem , Niacinato de Xantinol/administração & dosagem
3.
Int J Cancer ; 126(2): 583-8, 2010 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-19585554

RESUMO

The tumor micro-environment plays a key role in the tumor resistance to cytotoxic treatments. It has been demonstrated that it is possible to modulate the tumor microenvironment to potentiate anti-cancer therapy. Here, we made the hypothesis that the vasoactive agent xanthinol nicotinate (XN) could be an important modulator of the tumor perfusion and oxygenation. Using functional non invasive techniques (in vivo EPR oximetry and dynamic contrast enhanced MRI), we were able to define a time window in which tumor oxygenation, flow and permeability were significantly increased in the TLT tumor model implanted in muscles of mice. As a consequence of the alleviation of tumor hypoxia, we found out that XN was able to radiosensitize the tumors when applying 10 Gy of X-Rays during the reoxygenation of the tumors (enhancement in radiation response of 1.4). Moreover, the administration of cyclosphosphamide (50 mg/kg) used as a chemotherapeutic agent was more efficient when applying the treatment after XN administration (enhancement in response to chemotherapy of 2.7). These results show the importance of the dynamic evolution of the tumor microenvironment on the response to treatments, and that XN is an efficient modulator of the tumor hemodynamics that may potentiate cytotoxic treatments.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Experimentais/tratamento farmacológico , Radiossensibilizantes/farmacologia , Niacinato de Xantinol/farmacologia , Animais , Antineoplásicos Alquilantes/administração & dosagem , Terapia Combinada , Ciclofosfamida/uso terapêutico , Hemodinâmica/efeitos dos fármacos , Hemodinâmica/efeitos da radiação , Imageamento por Ressonância Magnética , Masculino , Camundongos , Camundongos Endogâmicos , Neoplasias Experimentais/patologia , Neoplasias Experimentais/radioterapia , Radiossensibilizantes/administração & dosagem , Fatores de Tempo , Resultado do Tratamento , Carga Tumoral/efeitos dos fármacos , Carga Tumoral/efeitos da radiação , Vasodilatadores/farmacologia , Terapia por Raios X/métodos , Niacinato de Xantinol/administração & dosagem
4.
Eksp Klin Gastroenterol ; (3): 22-5, 118, 2002.
Artigo em Russo | MEDLINE | ID: mdl-12353381

RESUMO

The study of the microvessels in bioptates of gastric mucosa and micro haemocirculation in the conjunctiva of 254 patients with chronic gastritis revealed that exacerbation of the gastric process is going on the background of hard terminal bloodstream disorders. They have the generalized character and picture of the typical chronic relapsing trombohaemorrhagic syndrome. The use of Prodectin (250 mg), Teonicolum (150 mg), Redergin (1 tab.) and Aescuzan (25 dr.) 4 times per day during 3 weeks helps to eliminate the microcirculatory disorders and exacerbation of the chronic gastritis.


Assuntos
Mesilatos Ergoloides/uso terapêutico , Escina/uso terapêutico , Gastrite/tratamento farmacológico , Fármacos Gastrointestinais/uso terapêutico , Piridinolcarbamato/uso terapêutico , Niacinato de Xantinol/uso terapêutico , Quimioterapia Combinada , Mesilatos Ergoloides/administração & dosagem , Escina/administração & dosagem , Feminino , Fármacos Gastrointestinais/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Piridinolcarbamato/administração & dosagem , Niacinato de Xantinol/administração & dosagem
6.
Vestn Oftalmol ; 113(6): 17-9, 1997.
Artigo em Russo | MEDLINE | ID: mdl-9483992

RESUMO

The authors analyze the results of treating atherosclerotic maculodystrophies by direct laser phoresis. The method consists in insertion of a collagen infusion system in Tenon's space. Drugs (nicotinic acid or xanthinol nicotinate) are delivered to the posterior compartment of the eye through this system. Then a light guide is inserted in the tube and a 2-min session of low-intensity He-Ne laser exposure is performed at a wavelength of 630 nm, and 10 mWt/cm2 flow power density (7 to 10 sessions per course). Clinical studies showed that vision acuity increased by an average of 0.08 diopters, or by 40% of the initial level, in 72% of cases. The peripheral visual field extended by an average of 51.4 degrees for 8 meridians in 95% of patients. The index of critical frequency of flashings fusing and the frequency-contrast characteristics improved in 85% of cases. The rheography improved by 34.5% of the initial level. A stable improvement was observed for 12 months after a course of direct laser phoresis in 97.5% of patients. Hence, the new method is simple and recommended for the treatment of atherosclerotic maculodystrophies.


Assuntos
Arteriosclerose/complicações , Degeneração Macular/terapia , Niacina/administração & dosagem , Fotoferese/métodos , Vasodilatadores/administração & dosagem , Niacinato de Xantinol/administração & dosagem , Arteriosclerose/fisiopatologia , Colágeno , Seguimentos , Humanos , Infusões Parenterais , Lasers , Degeneração Macular/etiologia , Degeneração Macular/fisiopatologia , Pessoa de Meia-Idade , Resultado do Tratamento , Acuidade Visual/fisiologia , Campos Visuais/fisiologia
7.
Klin Oczna ; 94(1): 18-9, 1992 Jan.
Artigo em Polonês | MEDLINE | ID: mdl-1635363

RESUMO

21 patients (40 eyes) aged 27-84 years (15 women and 6 men) were treated orally with cavinton 3 x 5 mg, sadamine++ 3 X 75 mg, cinnarizine++ 3 X 40 mg, vit. A+E 3 X 1 caps. daily. Intramuscularly++ were given vit. B1 25 mg, vit. B12 1000 micrograms, geriocaine++ 100 mg, and not in all sadamine++ 300 mg daily. Improvement of visual acuity for distance was observed in 31 eyes (77.5%) and for near vision in 17 eyes (42.5%). Within 34 eyes with visual field abnormalities in 9 the central or pericentral scotomas were observed. After medical treatment the central scotomas were diminished in 6 eyes (66.6%) and the enlargement of peripheral visual border from 10 to 30 degree in 10 eyes (40%) were observed.


Assuntos
Cinarizina/administração & dosagem , Degeneração Macular/tratamento farmacológico , Procaína/administração & dosagem , Alcaloides de Vinca/administração & dosagem , Vitaminas/administração & dosagem , Niacinato de Xantinol/administração & dosagem , Administração Oral , Adulto , Idoso , Quimioterapia Combinada , Feminino , Humanos , Injeções Intramusculares , Degeneração Macular/fisiopatologia , Masculino , Pessoa de Meia-Idade , Acuidade Visual/efeitos dos fármacos , Acuidade Visual/fisiologia
8.
Kardiologiia ; 32(1): 18-21, 1992 Jan.
Artigo em Russo | MEDLINE | ID: mdl-1614014

RESUMO

The paper analyzes the results of the treatment of 26 patients with atherosclerosis obliterans of the lower extremities, which has been performed to make an intensive hypolipidemic preparation for an operation. The comprehensive approach based on the combination of medication (nicotinic acid, and its derivatives, cholestyramine, and SKH -2K charcoal hemoperfusion ) and efferent therapy reduced the plasma levels of total cholesterol by 27%, triglycerides to 48%, low density lipoprotein cholesterol to 40%, and increased high density lipoprotein cholesterol up to 72%. The similar course therapy may be repeatedly used in a follow-up of this group of patients.


Assuntos
Arteriosclerose Obliterante/sangue , Carvão Vegetal/administração & dosagem , Colesterol/sangue , Hemoperfusão/métodos , Perna (Membro)/irrigação sanguínea , Triglicerídeos/sangue , Niacinato de Xantinol/administração & dosagem , Anticolesterolemiantes , Arteriosclerose Obliterante/cirurgia , Humanos , Hipolipemiantes , Pessoa de Meia-Idade , Cuidados Pré-Operatórios , Triglicerídeos/antagonistas & inibidores
10.
Artigo em Russo | MEDLINE | ID: mdl-1659073

RESUMO

Analysis of 210 cases of brain concussion and contusion showed that the general cerebral and focal symptoms of trauma of the brain are pronounced much more markedly and persist longer in combination of craniocerebral trauma (CCT) and diabetes mellitus than in CCT and normal blood sugar content. Inclusion of vasoactive agents Cavinton and Complamin into the scheme of complex therapy accelerates regression of the neurological symptomatology. The clinical course of diabetes mellitus may be aggravated by the CCT, which shows that additional correction of antidiabetic therapy is necessary.


Assuntos
Lesões Encefálicas/fisiopatologia , Complicações do Diabetes , Ferimentos não Penetrantes/fisiopatologia , Doença Aguda , Adulto , Idoso , Idoso de 80 Anos ou mais , Glicemia/análise , Concussão Encefálica/sangue , Concussão Encefálica/tratamento farmacológico , Concussão Encefálica/fisiopatologia , Lesões Encefálicas/sangue , Lesões Encefálicas/tratamento farmacológico , Circulação Cerebrovascular , Diabetes Mellitus/sangue , Diabetes Mellitus/fisiopatologia , Hemodinâmica , Humanos , Pessoa de Meia-Idade , Vasodilatadores/administração & dosagem , Alcaloides de Vinca/administração & dosagem , Ferimentos não Penetrantes/sangue , Ferimentos não Penetrantes/tratamento farmacológico , Niacinato de Xantinol/administração & dosagem
11.
Ortop Travmatol Protez ; (7): 36-8, 1991 Jul.
Artigo em Russo | MEDLINE | ID: mdl-1762734

RESUMO

In the process of treatment of experimental close fractures of radius in rats by intramuscular administration of benzofurocaine (60 mg/kg), the regeneration processes of the bone tissue were activated to a greater degree than in case of administration of etadene (20 mg/kg) or xanthinol nicotinate (30 mg/kg). Under the influence of benzofurocaine, beginning on the 10-20-th day of the experiment, there have been noted the reorganization of young callus into the mature laminal bone. The preparations of comparison have demonstrated less expressed analogous action.


Assuntos
Adenina/análogos & derivados , Anestésicos Locais/farmacologia , Anti-Inflamatórios não Esteroides/farmacologia , Regeneração Óssea/efeitos dos fármacos , Protetores contra Radiação/farmacologia , Niacinato de Xantinol/farmacologia , Adenina/administração & dosagem , Adenina/farmacologia , Anestésicos Locais/administração & dosagem , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Benzofuranos , Feminino , Injeções Intramusculares , Masculino , Protetores contra Radiação/administração & dosagem , Fraturas do Rádio , Ratos , Niacinato de Xantinol/administração & dosagem
14.
Laryngol Rhinol Otol (Stuttg) ; 67(4): 171-6, 1988 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-3386368

RESUMO

Analysis of 548 cases of sudden deafness shows impressively the importance of an infusion therapy with drugs improving the circulation which should be started as soon as possible. The greatest success could be made in the deep frequencies, whereas in the high frequencies the results were lower by nearly 8 decibels. Patients with sudden deafness on both sides or recurrent sudden deafness showed significantly less improvement of hearing than patients with first-time sudden deafness on one side. Remarkable is the continuous growth of sudden deafness in the low frequencies only, a phenomenon which was rarely seen one generation ago. Can this be interpreted as a change in the pattern of sudden deafness?


Assuntos
Perda Auditiva Súbita/terapia , Adolescente , Adulto , Idoso , Audiometria de Tons Puros , Terapia Combinada , Feminino , Seguimentos , Perda Auditiva Súbita/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Nafronil/administração & dosagem , Percepção da Altura Sonora/efeitos dos fármacos , Cloreto de Sódio/administração & dosagem , Niacinato de Xantinol/administração & dosagem
15.
Atherosclerosis ; 69(2-3): 97-101, 1988 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-3279969

RESUMO

A low-dose combination of Complamin retard (1 g t.i.d.) and cholestyramine (4 g b.i.d.) was compared with each agent alone in 2 serial open trials without dietary restriction using type IIa and IIb hyperlipoproteinaemic patients. Complamin alone produced decreases in LDL and VLDL cholesterol concentrations (up to 20%) whereas cholestyramine alone produced only a modest reduction in LDL (up to 15%). The combination produced marked, progressive reductions in total cholesterol (up to 35%) and LDL (up to 40%); reductions in VLDL (up to 45%), total triglyceride (up to 60%) and free fatty acids (up to 60%) were found only in type IIb patients. The average increase in HDL-cholesterol from the 2 studies for combination therapy was 35%. No side-effects were reported or measured and compliance was excellent. The results demonstrate the potential of a method of achieving beneficial actions on lipoprotein levels with a well-tolerated therapy.


Assuntos
HDL-Colesterol/sangue , LDL-Colesterol/sangue , Resina de Colestiramina/uso terapêutico , Hiperlipoproteinemia Tipo II/tratamento farmacológico , Teofilina/análogos & derivados , Niacinato de Xantinol/uso terapêutico , Adulto , Colesterol/sangue , VLDL-Colesterol , Resina de Colestiramina/administração & dosagem , Ensaios Clínicos como Assunto , Quimioterapia Combinada , Humanos , Lipoproteínas VLDL/sangue , Masculino , Pessoa de Meia-Idade , Niacinato de Xantinol/administração & dosagem
20.
Z Alternsforsch ; 38(5): 383-8, 1983.
Artigo em Alemão | MEDLINE | ID: mdl-6659567

RESUMO

71 patients (42 men and 29 women, aged between 45 and 76) with primary hyperlipoproteinaemia (HLP) types IIa, IIb and IV, were treated with clofibric acid (Regadrin) and nicotinic acid derivatives (Radecol, Jupol) over a three-year period. Every four months, they underwent gas chromatographic analyses of the fatty acid spectrum (fa) in the fractions of cholesterol ester (Chol.E) and triglyceride (TGL) of the serum. The therapy resulted in an increase in the linoleic, linolenic, arachidonic, and eicosapentaenoic acids, and a fall in the palmitic, palmitoleic, stearic, oleic and eicosatrienic acid levels in the Chol.E fraction in the case of HLP types IIa and IIb, and in the TGL fraction in the case of HLP types IIb and IV. Selective competitive inhibition by unesterified fatty acids, blocked lipolysis, an impaired hepatogenic fatty-acid metabolism, an affected LCAT and an increased esterification of polyunsaturated fatty acids are discussed as possible mechanisms. The increase in polyunsaturated fatty acids and the decrease of saturated and monounsaturated fatty acids must be considered, as they are interrelated with the prostaglandin metabolism, to be a positive and vasoprotective effect which assumes special importance in middle and older age.


Assuntos
Clofibrato/análogos & derivados , Ácido Clofíbrico/administração & dosagem , Ácidos Graxos/sangue , Hiperlipoproteinemia Tipo II/tratamento farmacológico , Hiperlipoproteinemia Tipo IV/tratamento farmacológico , Álcool Nicotinílico/administração & dosagem , Piridinas/administração & dosagem , Teofilina/análogos & derivados , Niacinato de Xantinol/administração & dosagem , Idoso , Ésteres do Colesterol/sangue , Ácido Clofíbrico/uso terapêutico , Quimioterapia Combinada , Feminino , Humanos , Hiperlipoproteinemia Tipo II/sangue , Hiperlipoproteinemia Tipo IV/sangue , Masculino , Pessoa de Meia-Idade , Álcool Nicotinílico/uso terapêutico , Triglicerídeos/sangue , Niacinato de Xantinol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...